WebMay 3, 2024 · Objectives: To assess how a decade of developments in systematic anticancer therapy (SACT) for advanced non-small cell lung cancer (NSCLC) affected … WebDec 1, 2024 · The diversity of SACT now available has resulted in a wide profile of toxicities, which require prompt identification and timely intervention to reduce morbidity and mortality. In particular, immunotherapy-related adverse events require specific management with immunosuppression in moderate-to-severe cases.
30-day mortality after systemic anticancer treatment for …
WebMore deaths occurred in SACT-naïve patients and during the first two cycles of therapy. Of the deaths, 28% was attributed to SACT, while 59.7% was attributed to cancer progression. Conclusion: We demonstrated the feasibility of this index for auditing practice in smaller oncology units over a longer timeframe. Keywords: WebMar 15, 2024 · This study aimed to look at rate of SARS-CoV-2 infection and mortality in patients with skin malignancies receiving systemic anti-cancer therapy (SACT) during the pandemic in Guy’s Cancer Centre. Methods: All patients with skin cancer receiving SACT at Guy’s Cancer Centre between March 1 st and May 31 st 2024 were included. Demographic … toth pc
30-Day Mortality Following Systemic Anti-Cancer …
WebNov 23, 2024 · The 30-day mortality rate for our center was 3.89% for patients receiving SACT and 4.9% of all-cause mortality. In the 30-day mortality cohort the median patient age at death was 71 years (interquartile range (IQR) 52-86); ratio of men to women, 1.18. 30-day mortality increased with age for patients treated with palliative intent or intent to ... WebFeb 20, 2024 · Through first-hand experience, Prof Wardley relates to the need for better access to systemic anti-cancer therapy (SACT) drug treatment. SACT delivery increases at ~10-15% per year, greatly improving survival rates for cancer patients., but placing an increasing challenge on health care delivery and staff. ... • reporting of 30-day mortality ... WebThe 30-day post-SACT mortality rate was calculated, and regimen changes in the last 14 days of life were identified. Univariate analysis and multivariate logistic regression were used to identify demographic, tumor and treatment-related factors that correlated with mortality risk. RESULTS: 1044 patients receiving ≥ 1 cycle of SACT in 2005 ... potato salad made with oil